The Echinococcus granulosus antigen EgA31: localization during development and immunogenic properties

Area of Science:

• Parasitology
• Immunology
• Molecular Biology

Background:

• Echinococcus granulosus infestation poses a significant health challenge.
• EgA31 is identified as a key antigen in dogs during parasitic infection.
• Understanding EgA31's localization and immunogenicity is crucial for control strategies.

Purpose of the Study:

• To investigate the precise localization of the EgA31 antigen within the Echinococcus granulosus parasite.
• To assess the immunogenicity of different EgA31 protein domains during experimental canine infection.
• To explore the diagnostic and vaccine potential of EgA31 and its fragments.

Main Methods:

• Immunohistochemistry was employed for antigen localization using optical and electron microscopy.
• Experimental infection of dogs was conducted to evaluate protein domain immunogenicity.
• Analysis of the complete cDNA and specific fragments (Pst I-Hind III) was performed.

Main Results:

• EgA31 was predominantly found in the microtriches and subtegumental cells of adult parasites.
• The antigen was also detected in eggs, calcareous corpuscles, and the germinal layer.
• The polypeptide encoded by the Pst I-Hind III fragment demonstrated the highest antigenicity during infection.

Conclusions:

• EgA31 exhibits specific localization patterns within the Echinococcus granulosus life cycle.
• A distinct polypeptide fragment of EgA31 is highly immunogenic in infected dogs.
• This immunogenic fragment holds promise for developing diagnostic tools and candidate vaccines against Echinococcus granulosus.